North America Clinical Laboratory Tests Market Size & Outlook
North America clinical laboratory tests market, 2018-2030 (US$M)
Related Markets
North America clinical laboratory tests market highlights
- The North America clinical laboratory tests market generated a revenue of USD 55,982.8 million in 2023.
- The market is expected to grow at a CAGR of 7.1% from 2024 to 2030.
- In terms of segment, lipid panel tests was the largest revenue generating type in 2023.
- HGB/HCT tests is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 55,982.8 million |
| Market revenue in 2030 | USD 90,774.0 million |
| Growth rate | 7.1% (CAGR from 2023 to 2030) |
| Largest segment | Lipid panel tests |
| Fastest growing segment | HGB/HCT tests |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Complete blood count, HGB/HCT tests, Basic metabolic panel, BUN creatinine tests, Electrolytes testing, HbA1c tests, Comprehensive metabolic panel tests, Liver panel tests, Renal panel tests, Lipid panel tests |
| Key market players worldwide | Quest Diagnostics Inc, Abbott Laboratories, Labcorp Holdings Inc, ARUP Laboratories, OPKO Health Inc, Clinical Reference Laboratory, Sonic Healthcare Ltd, Cinven, Unilabs |
Other key industry trends
- In terms of revenue, North America region accounted for 48.8% of the global clinical laboratory tests market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 49,664.3 million by 2030.
Lipid panel tests was the largest segment with a revenue share of 12.44% in 2023. Horizon Databook has segmented the North America clinical laboratory tests market based on complete blood count, hgb/hct tests, basic metabolic panel, bun creatinine tests, electrolytes testing, hba1c tests, comprehensive metabolic panel tests, liver panel tests, renal panel tests, lipid panel tests covering the revenue growth of each sub-segment from 2018 to 2030.
North America is the most developed clinical laboratory tests market. The increasing geriatric population, rising prevalence of chronic diseases such as cancer, and high market penetration of technologically advanced diagnostic techniques are expected to drive market growth over the forecast period.
Moreover, market players are now focusing on improvised and software-enabled automated diagnostic systems that help in managing and processing hundreds of samples at a time as well as obtaining accurate results. According to WHO, the prevalence of gestational anemia varies from 5% to 20% in North America.
To identify anemia in pregnant women, government bodies recommend screening for anemia and risks of iron deficiency. For instance, government bodies such as CDC, American Congress of Obstetricians and Gynecologists, and American Academy of Family Physicians strongly recommend universal anemia screening in North America.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Laboratory Tests Market Scope
Clinical Laboratory Tests Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America clinical laboratory tests market size, by country, 2018-2030 (US$M)
North America Clinical Laboratory Tests Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
